TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+11%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$107B
AUM Growth
+$5.79B
(+5.7%)
Cap. Flow
-$2.63B
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
24.55%
Holding
1,462
New
74
Increased
672
Reduced
527
Closed
81
Top Buys
| 1 |
AbbVie
ABBV
|
+$386M |
| 2 |
Procter & Gamble
PG
|
+$310M |
| 3 |
Meta Platforms (Facebook)
META
|
+$292M |
| 4 |
CRH
CRH
|
+$276M |
| 5 |
Republic Services
RSG
|
+$267M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
Apple
AAPL
|
+$780M |
| 3 |
UnitedHealth
UNH
|
+$465M |
| 4 |
Microsoft
MSFT
|
+$445M |
| 5 |
NVIDIA
NVDA
|
+$433M |
Sector Composition
| 1 | Technology | 20.15% |
| 2 | Financials | 19.67% |
| 3 | Healthcare | 11.58% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENV
976
DELISTED
ENVESTNET, INC.
ENV
| $2.26M | ﹤0.01% |
39,034
+3,200
| +9% | +$185K |
|
977
US Physical Therapy
USPH
$1.24B
| $2.25M | ﹤0.01% |
19,950
| – | – |
|
978
Franklin Resources
BEN
$12.6B
| $2.25M | ﹤0.01% |
80,076
+2,714
| +4% | +$76.3K |
|
979
H.B. Fuller
FUL
$3.31B
| $2.25M | ﹤0.01% |
28,166
+8,400
| +42% | +$670K |
|
980
Immunovant
IMVT
$2.84B
| $2.23M | ﹤0.01% |
69,042
+2,734
| +4% | +$88.3K |
|
981
BJ's Restaurants
BJRI
$696M
| $2.22M | ﹤0.01% |
61,404
-3,200
| -5% | -$116K |
|
982
Core & Main
CNM
$9.26B
| $2.22M | ﹤0.01% |
+38,774
| New | +$2.22M |
|
983
Neogen
NEOG
$1.22B
| $2.22M | ﹤0.01% |
140,516
+4,366
| +3% | +$68.9K |
|
984
AMN Healthcare
AMN
$754M
| $2.21M | ﹤0.01% |
35,300
+4,400
| +14% | +$275K |
|
985
FB Financial Corp
FBK
$2.87B
| $2.2M | ﹤0.01% |
58,304
+3,800
| +7% | +$143K |
|
986
Wyndham Hotels & Resorts
WH
$6.46B
| $2.19M | ﹤0.01% |
28,568
| – | – |
|
|
AUTL
987
Autolus Therapeutics
AUTL
$362M
| $2.18M | ﹤0.01% |
342,406
+207,106
| +153% | +$1.32M |
|
988
DT Midstream
DTM
$10.8B
| $2.18M | ﹤0.01% |
35,600
| – | – |
|
989
Andersons Inc
ANDE
$1.36B
| $2.17M | ﹤0.01% |
37,900
+4,400
| +13% | +$252K |
|
990
OFG Bancorp
OFG
$1.97B
| $2.17M | ﹤0.01% |
59,000
+4,000
| +7% | +$147K |
|
991
Cabaletta Bio
CABA
$158M
| $2.17M | ﹤0.01% |
127,030
+33,400
| +36% | +$570K |
|
992
FMC
FMC
$4.63B
| $2.16M | ﹤0.01% |
33,977
-300
| -0.9% | -$19.1K |
|
993
iShares Core S&P 500 ETF
IVV
$668B
| $2.15M | ﹤0.01% |
4,096
+494
| +14% | +$260K |
|
994
iShares MSCI Australia ETF
EWA
$1.54B
| $2.15M | ﹤0.01% |
87,294
-149
| -0.2% | -$3.67K |
|
995
Lyell Immunopharma
LYEL
$252M
| $2.15M | ﹤0.01% |
48,192
+2,380
| +5% | +$106K |
|
996
DXC Technology
DXC
$2.55B
| $2.15M | ﹤0.01% |
101,300
+41,000
| +68% | +$870K |
|
997
Evertec
EVTC
$2.14B
| $2.14M | ﹤0.01% |
53,759
-6,137
| -10% | -$245K |
|
998
Pricesmart
PSMT
$3.39B
| $2.14M | ﹤0.01% |
25,500
+700
| +3% | +$58.8K |
|
999
Prosperity Bancshares
PB
$6.39B
| $2.14M | ﹤0.01% |
32,514
+26,514
| +442% | +$1.74M |
|
1000
Praxis Precision Medicines
PRAX
$835M
| $2.14M | ﹤0.01% |
+35,000
| New | +$2.14M |
|